7.65
Mimedx Group Inc stock is traded at $7.65, with a volume of 2.79M.
It is up +3.38% in the last 24 hours and up +9.60% over the past month.
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
See More
Previous Close:
$7.40
Open:
$7.35
24h Volume:
2.79M
Relative Volume:
3.77
Market Cap:
$1.13B
Revenue:
$342.81M
Net Income/Loss:
$97.67M
P/E Ratio:
12.45
EPS:
0.6145
Net Cash Flow:
$50.46M
1W Performance:
+13.17%
1M Performance:
+9.60%
6M Performance:
+11.19%
1Y Performance:
+11.68%
Mimedx Group Inc Stock (MDXG) Company Profile
Name
Mimedx Group Inc
Sector
Industry
Phone
(770) 651-9100
Address
1775 W OAK COMMONS COURT, NE, MARIETTA
Compare MDXG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 6.49 | 0 | 0 | 0 | 0 | 0.00 | |
|
MOBBW
Mobilicom Limited Warrants
|
3.32 | 3.71B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.07 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
4.40 | 174.62M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.2615 | 587.26M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.31 | 0 | 0 | 0 | 0 | 0.00 |
Mimedx Group Inc Stock (MDXG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-02-24 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-07-24 | Initiated | Lake Street | Buy |
| Oct-27-23 | Initiated | Craig Hallum | Buy |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Jul-26-21 | Initiated | Northland Capital | Outperform |
| Mar-19-21 | Initiated | H.C. Wainwright | Buy |
View All
Mimedx Group Inc Stock (MDXG) Latest News
Cantor Fitzgerald Predicts Higher Earnings for MiMedx Group - MarketBeat
Is MiMedx Group Inc. stock a safe investment in uncertain marketsWeekly Trend Summary & Daily Growth Stock Tips - newser.com
MiMedx Shares Surge on Strong Earnings and Favorable Regulatory Outlook - AD HOC NEWS
MiMedx Group (NASDAQ:MDXG) Raised to "Strong-Buy" at Wall Street Zen - MarketBeat
MiMedx Group (NASDAQ:MDXG) Rating Increased to Strong-Buy at Wall Street Zen - MarketBeat
Will a bounce in MiMedx Group Inc. offer an exitJuly 2025 Price Swings & Breakout Confirmation Alerts - newser.com
MiMedx Group (NASDAQ:MDXG) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
Northland Capmk Forecasts Stronger Earnings for MiMedx Group - MarketBeat
Why MiMedx Group Inc. stock appeals to dividend seekersWeekly Investment Summary & Real-Time Market Sentiment Reports - newser.com
Will MiMedx Group Inc. stock outperform growth indexesPortfolio Risk Summary & Daily Entry Point Alerts - newser.com
Will MiMedx Group Inc. stock go up soonTrend Reversal & Accurate Intraday Trade Tips - newser.com
MiMedx Group (NASDAQ:MDXG) Shares Gap Up After Better-Than-Expected Earnings - MarketBeat
Analysts Offer Insights on Healthcare Companies: MiMedx Group (MDXG), TransMedics Group (TMDX) and Arcus Biosciences (RCUS) - The Globe and Mail
Is MiMedx Group Inc. stock a buy for dividend growth2025 Volume Leaders & Expert Curated Trade Ideas - newser.com
Using data models to predict MiMedx Group Inc. stock movementSwing Trade & Community Verified Trade Signals - newser.com
Will MiMedx Group Inc. stock reach Wall Street targetsMarket Activity Report & Daily Profit Focused Stock Screening - newser.com
MiMedx Group Reports Strong Q3 2025 Financial Results - The Globe and Mail
Is MiMedx Group Inc. stock attractive for ETFsGap Down & Stepwise Trade Signal Implementation - newser.com
MiMedx Group (MDXG): Margin Decline Challenges Bullish Narratives Despite Strong Earnings Growth - Yahoo Finance
MiMedx Group Inc. Reports Record Q3 Revenue - TipRanks
MiMedx Group (NASDAQ:MDXG) Releases Earnings Results, Beats Expectations By $0.08 EPS - MarketBeat
MiMedx Group Inc (MDXG) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... By GuruFocus - Investing.com Canada
MiMedx Group Reports Record Q3 2025 Revenue Growth - The Globe and Mail
MiMedx Group Inc (MDXG) Q3 2025 Earnings Call Highlights: Record - GuruFocus
MiMedx (MDXG) Q3 2025 Earnings Call Transcript - AOL.com
MiMedx Group, Inc. (NASDAQ:MDXG) Q3 2025 Earnings Call Transcript - Insider Monkey
Institutional investors are MiMedx Group, Inc.'s (NASDAQ:MDXG) biggest bettors and were rewarded after last week's US$70m market cap gain - simplywall.st
Decoding MiMedx Group Inc (MDXG): A Strategic SWOT Insight - GuruFocus
What indicators show strength in MiMedx Group Inc.2025 Volatility Report & Intraday High Probability Alerts - newser.com
MiMedx: Q3 Earnings Snapshot - Chron
MiMedx raises 2025 revenue growth outlook to mid- to high teens as company posts record quarterly sales - MSN
MIMEDX (MDXG) Anticipates Strong Future with Strategic Adaptatio - GuruFocus
Transcript : MiMedx Group, Inc., Q3 2025 Earnings Call, Oct 29, 2025 - MarketScreener
MiMedx Group Inc (MDXG) Q3 2025 Earnings: EPS of $0.15 Beats Est - GuruFocus
MiMedx Q3 2025 Earnings: $16.7M Net Income, $113.7M RevenueNews and Statistics - IndexBox
MiMedx Group Inc. Profit Advances In Q3 - Nasdaq
Earnings Flash (MDXG) MiMedx Group, Inc. Reports Q3 Revenue $113.7M, vs. FactSet Est of $94.7M - MarketScreener
MIMEDX Announces Record Revenue for Third Quarter 2025 - The Manila Times
MiMedx Q3 net sales beat estimates - TradingView
Earnings Flash (MDXG) MiMedx Group, Inc. Posts Q3 Adjusted EPS $0.15 per Share, vs. FactSet Est of $0.06 - MarketScreener
MiMedx updates Q3 2025 results with exhibits 99.1–99.3 - Stock Titan
MDXG Q3 2025: Revenue up 35%, net income $16.7M - Stock Titan
Is MiMedx Group Inc. stock a defensive play in 2025Quarterly Trade Review & Consistent Income Trade Recommendations - Fundação Cultural do Pará
Mimedx Group Inc Stock (MDXG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):